Carbidopa monohydrate

SKU: orb1306338

Description

Carbidopa monohydrate is a selective DOPA decarboxylase inhibitor used in research to block the peripheral conversion of levodopa to dopamine. It is a key tool in neuroscience and pharmacology for modeling Parkinson's disease and studying dopaminergic pathways in both in vitro and in vivo experimental systems.

Research Area

Immunology & Inflammation, Metabolism Research

Key Properties

• CAS Number: 38821-49-7
• MW: 244.24
• Purity: 99.29%
• Formula: C₁₀H₁₆N₂O₅
• SMILES: CC(CC1=CC=C(O)C(O)=C1)(NN)C(O)=O
• Target: Aryl Hydrocarbon Receptor,Decarboxylase
• Solubility: DMSO:5.5 mg/mL (22.52 mM)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

AhR, cancer, Carbidopa, Carbidopa Hydrate, Carbidopa Monohydrate, Carbidopa monohydrate, ArylHydrocarbonReceptor, Aryl Hydrocarbon Receptor, aromatic-L-amino-acid decarboxylase, disease, Inhibitor, Parkinson's, pancreatic, inhibit, peripheral, SCarbidopa, S(-)-Carbidopa

Compound Identifiers

PubChem CID

2563